Back to Search
Start Over
Pneumocystis jirovecii pneumonia as a complication of etoposide therapy
- Source :
- BMJ Case Rep
- Publication Year :
- 2021
- Publisher :
- BMJ Publishing Group, 2021.
-
Abstract
- Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Chemotherapy
business.industry
medicine.medical_treatment
Pneumocystis jirovecii Pneumonia
Case Report
General Medicine
T lymphocyte
030105 genetics & heredity
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Internal medicine
parasitic diseases
medicine
Corticosteroid use
Complication
business
Oral etoposide
030217 neurology & neurosurgery
Etoposide
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- BMJ Case Rep
- Accession number :
- edsair.doi.dedup.....9477f0129d4d3d70385036746437ecdf